Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans

Apolipoprotein A–V modulates multiple atherogenic mechanisms in a mouse model of disturbed clearance of triglyceride-rich lipoproteins

(2012) Itamar Grosskopf et al.   ATHEROSCLEROSIS

Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia

(2012) H. Carlijne Hassing et al.   HEPATOLOGY

A Comprehensive Compositional Analysis of Heparin/Heparan Sulfate-Derived Disaccharides from Human Serum

(2011) Wei Wei et al.   ANALYTICAL CHEMISTRY

Glucuronic Acid Epimerase is Associated with Plasma Triglyceride and High-Density Lipoprotein Cholesterol Levels in Turks

(2011) Uğur Hodoğlugil et al.   ANNALS OF HUMAN GENETICS

Apolipoprotein A-V; a potent triglyceride reducer

(2011) Stefan K. Nilsson et al.   ATHEROSCLEROSIS

Clinical Relevance of Non-Fasting and Postprandial Hypertriglyceridemia and Remnant Cholesterol

(2011) Borge G. Nordestgaard et al.   Current Vascular Pharmacology

Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement

(2011) Genovefa D. Kolovou et al.   Current Vascular Pharmacology

Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance

(2011) Yiping Deng et al.   HEPATOLOGY

Intravenous Injection of Apolipoprotein A-V Reconstituted High-Density Lipoprotein Decreases Hypertriglyceridemia in apoav −/− Mice and Requires Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein–Binding Protein 1

(2010) Xiao Shu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

GPIHBP1 Is Responsible for the Entry of Lipoprotein Lipase into Capillaries

(2010) Brandon S.J. Davies et al.   Cell Metabolism

Recent insights into factors affecting remnant lipoprotein uptake

(2010) Kevin Jon Williams et al.   CURRENT OPINION IN LIPIDOLOGY

Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins

(2010) Keyang Chen et al.   HEPATOLOGY

Heparan Sulfate 2-O-Sulfotransferase Is Required for Triglyceride-rich Lipoprotein Clearance

(2009) Kristin I. Stanford et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice

(2009) Kristin I. Stanford et al.   JOURNAL OF CLINICAL INVESTIGATION

Atheroprotective Effect of Human Apolipoprotein A5 in a Mouse Model of Mixed Dyslipidemia

(2008) Roxane M. Mansouri et al.   CIRCULATION RESEARCH